Literature DB >> 22443078

Progression of cataracts following photodynamic therapy combined with intravitreous triamcinolone injection in cases of age-related macular degeneration.

Hisashi Iwami1, Takeya Kohno, Manabu Yamamoto, Mayumi Kaida, Norito Miki, Shinsuke Ataka, Kunihiko Shiraki.   

Abstract

BACKGROUND: To present long-term data on the progression of cataracts following photodynamic therapy (PDT) combined with 4 mg intravitreal triamcinolone acetonide (IVTA) for age-related macular degeneration (AMD).
METHODS: Fifty-seven phakic eyes of 56 patients underwent the treatment between October 2004 and November 2006. The follow-up period ranged from 12 to 38 months with 3 months interval of observation and repeated treatment at recurrence.
RESULTS: Cataract progression was noted in 40 eyes 5-21 months after treatment, consisting of 4 eyes between 3 and < 6 months after treatment, 22 eyes between 6 and < 12 months, 8 eyes between 12 and < 18 months, and 6 eyes between 18 and < 24 months. The percentage of the eyes with cataract progression began to decrease 5 months after treatment and, occurred most frequently during the period from 6 months to 12 months after treatment. There was no significant difference in age, follow-up period, or the frequency of the treatment between the cataract progression group and the non progression group. Twenty four eyes underwent surgery 10-31 months after treatment, showing significant improvement in visual acuity.
CONCLUSIONS: This study showed high incidence of cataract during a long-term follow-up after PDT combined with IVTA and significant reduction of visual acuity due to cataract.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22443078

Source DB:  PubMed          Journal:  Osaka City Med J        ISSN: 0030-6096


  3 in total

Review 1.  Vitreous function and intervention of it with vitrectomy and other modalities.

Authors:  Yao Zong; Qian-Ying Gao; Yan-Nian Hui
Journal:  Int J Ophthalmol       Date:  2021-10-18       Impact factor: 1.779

2.  Vitreous function and intervention of it with vitrectomy and other modalities.

Authors:  Yao Zong; Qian-Ying Gao; Yan-Nian Hui
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

3.  Clinical efficacy of intravitreal corticoid as an adjunctive therapy to anti-VEGF treatment of neovascular age-related macular degeneration: a Meta-analysis.

Authors:  Bo-Hao Cui; Wei Zhou; Wen-Wen Wang; Hao Yang; Ya-Lan Dong; Yuan-Yuan Liu; Hua Yan
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.